Clinical Trial Update: Pharmacokinetics, Safety and Efficacy Study of Proellex in Pre-menopausal Women With Symptomatic Uterine Fibroids [Phase 2]

View source ↗

Summary

A Phase 2 pharmacokinetics, safety and efficacy study of Proellex (telapristone acetate) for symptomatic uterine fibroids was terminated, with results posted in…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Uterine Fibroids

Drugs mentioned

• Proellex (telapristone acetate)

Snippet

Sponsor: Repros Therapeutics Inc. | Conditions: Uterine Fibroids | Phase 2 | Status: TERMINATED | Results posted: 2014-08-21